AgingResearch.NewsJoin free

Polypharmacy and limited medication literacy

Polypharmacy and limited medication literacy has been studied in 1 paper since 2024: 1 observational study in people. The newest paper, Apr 3, 2024: “The Role of Medication Literacy and Polypharmacy in Sarcopenia Among Maintenance Hemodialysis Patients: A Cross-Sectional Analysis”.

Exposure

1 paper studies it1 findingUpdated

See all 1

“the combination of polypharmacy and limited medication literacy (OR = 1.956, 95% CI: 1.094 to 3.496, P = 0.024) was significantly associated with an increased risk of sarcopenia progression”
The Role of Medication Literacy and Polypharmacy in Sarcopenia Among Maintenance Hemodialysis Patients: A Cross-Sectional AnalysisResearch Square2024doi:10.21203/rs.3.rs-4182028/v1

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funders: Sichuan University and 1 more
  • Humans1

What is Polypharmacy and limited medication literacy linked with?

1

Studies link Polypharmacy and limited medication literacy with 1 measure, most often sarcopenia (1 study).

Sarcopenia

upin humans1OR 1.956

1 study

  1. Polypharmacy and limited medication literacy is linked with a higher risk of sarcopenia in maintenance hemodialysis patients (OR = 1.956, 95% CI: 1.094 to 3.496, P = 0.024).

    “the combination of polypharmacy and limited medication literacy (OR = 1.956, 95% CI: 1.094 to 3.496, P = 0.024) was significantly associated with an increased risk of sarcopenia progression”

    Humansin maintenance hemodialysis patientsn = 236

    The Role of Medication Literacy and Polypharmacy in Sarcopenia Among Maintenance Hemodialysis Patients: A Cross-Sectional Analysis

    Research SquarePreprint

More on Sarcopenia

Latest

Related